A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety

In this first clinical trial liposome-encapsulated iodixanol, CT particles (CTP) were studied. The aims of the present trial were to assess the efficacy of CTP in CT and to determine the safety of different doses of CTP. A total of 47 healthy volunteers were enrolled in the present study. The CTP wa...

Full description

Saved in:
Bibliographic Details
Published inEuropean radiology Vol. 11; no. 4; pp. 698 - 704
Main Authors Leander, P, Höglund, P, Børseth, A, Kloster, Y, Berg, A
Format Journal Article
LanguageEnglish
Published Germany Springer Nature B.V 01.01.2001
Subjects
Online AccessGet full text

Cover

Loading…